India is strengthening supply chains by prioritizing energy and semiconductor sectors. The nation aims to reduce import dependence through ...

Britain has become the first country in Europe to approve orforglipron, the oral weight loss and diabetes treatment developed by US company...

Air India SATS Airport Services and Concor Air Limited have signed an initial pact. This collaboration aims to expedite cargo movement from...

On Tuesday, Indian stock markets experienced a downturn influenced by increasing oil prices and escalating tensions in the Middle East. Nev...

India’s medical device industry and healthcare groups have opposed the draft Drugs, Medical Devices and Cosmetics Bill, 2026, arguing that ...

2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...

For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

Will be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.

The new US legislative proposal aims to introduce tariffs on nations acquiring Russian energy, challenging India to balance its energy dema...

In 1897, a German chemist while trying to ease his father’s rheumatic pains accidentally developed a drug still widely used as an over-the-...

Doximity shares surged after the healthcare platform highlighted the strong performance of its clinical AI, overshadowing an earnings miss....

The panel suggested the commerce department prepare a time-bound roadmap to achieve the objectives of the Mission 500 initiative by promoti...

India has spent years negotiating free trade agreements with some of the world's biggest economies. But signing the deals was only half the...

European stocks advanced on Wednesday, driven by U.S.-Iran diplomatic talks. Mining companies led the rally as geopolitical concerns eased ...

The Indian Pharmaceutical Alliance seeks to regularize many drugs. These drugs have been marketed for years without central approval. Examp...

European shares saw modest gains as investors reviewed corporate earnings reports. Energy stocks edged higher while oil prices rebounded fr...

India's pharmaceutical industry is expected to reach$80-90 billion by 2030, well below its earlier$130 billion target, as U.S. tariff uncer...